Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

ContraFect ends enrolment in Phase ll trial of CF-301

This scanning electron micrograph (SEM) shows a strain of Staphylococcus aureus bacteria taken from a vancomycin intermediate resistant culture (VISA). Credit: PD-USGov-HHS-CDC.



Close
Close
Close

Go Top